A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer
| Autor: | Sternberg, C.N., Saad, F., Graff, J.N., Peer, A., Vaishampayan, U.N., Leung, E., Rosenbaum, E., Gurney, H., Epstein, R.J., Davis, I.D., Wu, B., Trandafir, L., Wagner, V.J., Hussain, M. |
|---|---|
| Zdroj: | In Annals of Oncology February 2020 31(2):257-265 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|